MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Location

Founded

1989-12-19

Website

https://www.medtronic.com

Risk Signals

9892 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Corporate Insolvency (9) Workforce Reductions (3) Ethics Violations Allegations (2) Business Growth Initiatives (2) Financial Reporting (2) Fraud Investigations (2) Insider Trading Violations (2) Legal Proceedings (2) Recruitment Activities (2) Revenue Generation Opportunities (2) Corporate Ethics and Governance (2) Corporate Governance Policies (2) Earnings Reports & Warnings (2) Acquisition Announcements (2) Executive Leadership Changes (2) Corporate Deals (1) Business Agreements (1) Initial Public Offering Launch (1) Business Resilience Planning (1) Corporate Restructuring (1) Public Health Crisis Response (1)

Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY

Live alerts from global media, monitored by Business Radar

2023-01-27 (axios.com)

Health Tech: Catch up quick

Wearable-sensor maker Rockley Photonics, which touted high-profile strategic partnerships with Apple and Medtronic, filed for Chapter 11 bankruptcy this week.

2020-03-29 (nytimes.com)

The U.S. Tried to Build a New Fleet of Ventilators. The Mission Failed.

As the coronavirus spreads, the collapse of the project helps explain America’s acute shortage.

2019-06-18 (medcitynews.com)

How Tandem Diabetes Care found its way back from near-bankruptcy - MedCity News

The San Diego-based company has is in the midst of one of the most precipitous turnarounds in the medical device industry and is well positioned to grow alongside the expanding insulin pump market.

2018-02-22 (massdevice.com)

B. Braun's Aesculap closes $17m Dextera Surgical bankruptcy buyout

Surgical instrument maker Dextera Surgical and B. Braun subsidiary Aesculap said yesterday that they closed the $17.3 million deal to buy Dextera out of Chapter 11 bankruptcy. Redwood City, Calif.- based Dextera, formerly known as Cardica, agreed to the buyout in December 2017.

2007-04-16 (informa.com)

Medtronic reorganization

Firm combines its vascular and cardiac surgery businesses on April 11 to support "the convergence of cardiovascular specialties focused on applying both surgical and minimally invasive approaches to patient care," says Scott Ward, head of the new business. The new entity, Medtronic CardioVascular,

(beckersspine.com)

Smith+Nephew records $5.5B in 2023 revenue

Discover the impressive growth of medtech company Smith+Nephew as they surpass $5 billion in 2023 revenue.